Analyst comments on Novo Nordisk's record-breaking stock price

On Tuesday, Novo Nordisk’s stock price has passed a milestone, which could indicate that investors are hoping for a guidance upgrade later this year, Sydbank Analyst Søren Løntoft Hansen says.
Photo: Novo Nordisk / PR
Photo: Novo Nordisk / PR
by marketwire, translated by daniel pedersen

A run of positive news of a smaller size is why Novo Nordisk’s stock price has increased so much that it broke its previous record on Tuesday, assesses Senior Equity Analyst at Sydbank Søren Løntoft Hansen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading